EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Antiarrhythmic activity of oximethers






Acta Physiologica Hungarica 83(3): 223-226

Antiarrhythmic activity of oximethers

More than sixty 2-substituted-cycloalkanone-oxim-/2-hydroxy-3-dialkylamino/- propylethers were investigated on aconitine induced ventricular arrhythmia model in rats. According to the structure-activity relationships cyclohexanes containing diisopropylamine in the basic group were the most effective derivatives. Based on the highest per os activity and lowest toxicity EGIS-3966 (ED50 values 1.21 mg/kg iv. and 27.3 mg/kg per os) was selected for further development.

(PDF 0-2 workdays service: $29.90)

Accession: 009770217

PMID: 8852647



Related references

Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil. Naunyn-Schmiedeberg's Archives of Pharmacology 294(3): 285-291, 1976

Comparison of the antiarrhythmic activity of sodium valproate and classical antiarrhythmic drugs in animals. Bulletin of Hunan Medical College 12(1): 5-9, 1987

The antiarrhythmic activity of the new antiarrhythmic drug bonnecor and its effect on the conductive system of the heart. Farmakologiya i Toksikologiya (Moscow) 53(3): 57-60, 1990

Structure-activity relationships of antiarrhythmic peptides A new group of antiarrhythmic agents. Circulation 96(8 SUPPL ): I292, 10/21/97, 1997

Potential antiarrhythmic agents. II. Antiarrhythmic activity of basic N-(substituted phenyl and benzyl)dipeptides. Acta Pharmaceutica Suecica 22(6): 321-334, 1985

Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties. Journal of Cardiovascular Pharmacology 21(4): 647-655, 1993

Antiarrhythmic activity of mdl 11939 a novel class iii antiarrhythmic agent. FASEB Journal 3(4): A1203, 1989

Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives. Archiv der Pharmazie 330(7): 225-231, 1997

Antiarrhythmic effects of antiarrhythmic peptide AAP10 in regional ischemia Improvement of cellular coupling as a new antiarrhythmic principle. Naunyn-Schmiedeberg's Archives of Pharmacology 354(4 SUPPL 1): R4, 1996

BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents. British Journal of Pharmacology 88(2): 333-343, 1986